Capricor Therapeutics (CAPR) has an average rating of overweight and mean price target of $29.35, according to analysts polled by FactSet.
Price: $3.00, Change: $-3.57, Percent Change: -54.34%
What else is happening in Research?
Research
Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target
Northland Securities Initiates Coverage on NeoVolta With Outperform Rating, $15 Price Target
$NEOV
Research
BofA Securities Upgrades Humana to Buy From Neutral, Raises Price Target to $500 From $410
Humana (HUM) has an average rating of hold and mean price target of $350.54, according to analysts polled by FactSet.Price: $365.15, Change: $-23.56, Percent Change: -6.06%
$HUM
Research
Oppenheimer Initiates Quince Therapeutics at Outperform With $82 Price Target
$QNCX